Bangladesh issues travel warnings as Covid-19 infections rise in neighbouring countries
A security personnel stands guard at the entrance of an isolation ward prepared for patients with Covid-19 symptoms at a government hospital in Secunderabad, Telangana on May 24, 2025. A Bangladesh directive stated that new subvariants of the coronavirus are spreading in several neighbouring countries. - AFP
DHAKA: Amid a fresh rise in Covid-19 infections in several neighbouring countries, the Bangladeshi interim government has asked people to refrain from traveling to those destinations unless absolutely necessary.
The Directorate General of Health Services (DGHS) under the Ministry of Health has also instructed the relevant authorities to enhance health screening and surveillance measures at all ports to contain the spread of the infection.
The directives which were issued Monday (June 10) stated that new subvariants of the coronavirus are spreading in several neighbouring countries.
To prevent potential transmission of these variants into Bangladesh, it said surveillance must be strengthened at International Health Regulations desks at all land, sea and airports for both inbound travelers from affected countries, and outbound travelers from Bangladesh to those destinations.
In line with the directives, people must wear masks at all gatherings, shopping malls and restaurants.
The DGHS asked the relevant authorities to use thermal scanners or digital handheld thermometers with non-contact techniques to measure body temperature at all entry points, ensure an adequate stock of masks, gloves and personal protective equipment for healthcare workers, and disseminate infection prevention guidelines to raise public awareness and prevent virus transmission.
Bangladesh on Thursday recorded its first Covid-19 fatality this year when a man died from the infectious disease in capital Dhaka. - Xinhua
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Star
2 hours ago
- The Star
Breaking the kush curse
SINGING sweetly as she packed her bag to leave the rehab centre, Mariama Turay vowed never again to smoke kush, the fearsome drug that wrecked her marriage – and countless lives in Sierra Leone. 'This drug is killing us slowly,' sighed the gentle-mannered 29-year-old, elegantly made up with shiny rings in her ears and nose. 'I'm promising myself that I am not going there anymore.' After seven weeks of therapeutic rehab under military guard with doctors and social workers, she is ready to go home to her parents. An hour's drive from the state-run centre where she was treated, desperate addicts who could not obtain therapeutic care lie chained to the floor for months in an informal detox house. 'The parents have nowhere to take their children,' said Hassan Kamara, the traditional healer who runs it. 'It's impossible to control their children. The suffering is too much.' Patients wearing T-shirts with the words 'Youth Lives Matter' leaving a government-operated rehab centre after finishing their programme in the outskirts of Freetown. — AFP Highly addictive Sierra Leone's President Julius Maada Bio in April 2024 declared a state of emergency due to a spike in deaths caused by kush, a synthetic drug containing powerful opioids and sometimes synthetic versions of cannabis-derived substances. Tests on kush in Sierra Leone found nitazenes, a synthetic opioid comparable to fentanyl, according to the Global Initiative Against Transnational Organised Crime. Cheap and highly addictive, kush can drive users psychotic, sparking hallucinations and damaging vital organs. Once an aspiring actress, Turay fell into its grips aged 27 while suffering the stress of marital problems. Her husband – himself a user and dealer – said the drug would help her sleep. 'It worked,' she said. But soon, she was wanting more, morning and evening. Her husband left and moved to Canada, where he received addiction treatment and remarried. Turay moved back in with her parents and her life fell apart. 'The drug was controlling me. My body ached until I smoked it,' she recalled. 'I sold my television, my wedding clothes, my wedding ring, because I didn't want men to use me – just for the drugs.' The national detox centre that treated her – until recently, the only one in the poverty-stricken country – has provided treatment to over 300 addicts since opening in February 2024. More than 2,000 are on the waiting list. Kamara said the centre he runs at his home in the Freetown suburbs has helped over 2,000 addicts recover through his 'healing process' of abrupt severance. Chained to beds On a visit to Kamara's barricaded house, six young men sprawled on filthy mattresses with iron chains restraining their ankles. Weakened by hunger and thirst and in some cases apparently sedated, they lay dazed with anguished looks in their eyes. 'I am OK with the treatment,' said one of them, Manso Koroma, under Kamara's watchful eye. After four months chained to the bed, 'I've recovered,' said Koroma, a 31-year-old man with a stricken expression and a haggard, scarred body. 'I'm just waiting for my sister to come and I can leave here.' A former motorcycle taxi rider, he had one leg amputated at the knee after a traffic accident – and took kush for the pain. 'When I came here, I was really violent. It took two days before the healer could start the healing process,' he said. Kush kills young people Kamara treats addicts with 'leaves from the forests and religious verses', he said, showing bottles of unidentified concoctions. 'I use the chain to protect them from escaping,' he said. 'I'm doing them good.' He acknowledged that his patients live in poor conditions but said his centre is under-resourced. He pleaded with the government for help. Ansu Konneh, director of mental health at the country's social welfare ministry, said the government wants to remove people from such unofficial sites, of which he estimates there are more than a dozen. 'A lot of violations against human rights is taking place in these informal centres,' he said. 'We cannot legitimise them by helping them.' A second official national rehab centre opened in the south on May 16. Fears of relapse In late April, Turay was among 52 former addicts aged 17 to 35 who walked out of the official rehab centre on the outskirts of Freetown. Most were at university when they became addicted. Some took selfies, singing and joking, but others wore haunted looks and spoke with voices still slurred from the effects of the drug. At her family home, Turay hugged her parents and brothers and asked them to forgive her. She kneeled at the feet of her father Ibrahim, 60. 'Thank you, God! Today my daughter is back home,' he said. 'I hope you've learned your lesson.' 'Of course,' she replied, sobbing. But her mother Aissata frets about relapse. 'I am worried that Mariama will go back to smoking because where we live, there are so many people who smoke kush.' In her bedroom, the young woman unpacked her belongings along with a manual: '12 steps for recovery for an addict'. She said she wants to go back to college, train as a beautician and one day 'have a child, if God blesses me with the right man'. — AFP
The Star
4 hours ago
- The Star
Teens push for digital detox trend
Working on their vision: LifeUp Organisation founders Li Xuan and her brother Yu Wei (right) interviewing a family about their experience with digital detox during one of their programmes this month. Siblings turn their struggle into a movement using interactive games and more JOHOR BARU: Like many teens, Liew Li Xuan developed an unhealthy screen addiction and was glued to her smartphone during the Covid-19 pandemic, which affected her grades and even sparked frequent arguments with her father. Now, the 18-year-old has turned her personal struggle into a movement to help other youths unplug from the digital world. 'Back then, I was addicted to doom-scrolling and spent excessive amounts of time online. I often argued with my father, who intervened by changing our home's Wi-Fi password and confiscating my phone. 'Although I was furious at the time, it was also a turning point. After some reflection, I realised I had to regain control of my life rather than let my unhealthy habits take over,' she said in an interview. Together with her 16-year-old brother Yu Wei, the siblings started LifeUp Organisation two years ago to promote digital detox and healthier online habits among children and teenagers. With the support from their father, the teens began conducting online and in-person activities to encourage digital well-being, tackle cyberbullying and educate youths on online scams. To date, they have attracted participants as young as 10 and older adults, using interactive methods such as mini games and puzzles to convey their message. 'We have seen that even children under 12, who have access to social media, are affected by curated content, which can harm their self-worth and confidence. 'This is why our work is important – to help them take a step back and live more intentionally,' said Li Xuan. She added that one of their most effective initiatives is their regular screen-time reduction challenge. 'We encouraged people to cut their screen time by at least 20%, but some managed to reduce it by up to 95% through conscious effort. That really encouraged us to keep going,' she said. The siblings fund their programmes through self-raised funds and sponsorships from multinational companies. Beyond digital detox workshops, the siblings, along with eight other volunteers, have also organised community service activities at charity homes in Johor Baru. Li Xuan's work also led to her appointment as a speaker under the Malaysian Communications and Multimedia Commission's Safe Internet Campaign, where she gives talks to pupils in Chinese schools in Johor on internet safety and healthy digital habits. 'Our group has recently started a podcast in hopes of reaching out to more people about the importance of taking a digital detox,' she added. Li Xuan, who will be pursuing A-Levels at a private college in Selangor this August, said she has gained valuable leadership and organisational experience through her activities. 'As my peers and I further our studies across the country, we hope to start similar movements in our respective campuses,' she added. Now that she has turned 18, Li Xuan hopes to formally register the group under the Registrar of Societies to expand their programmes and reach more communities. 'I want to continue this journey and inspire more young people to take charge of their digital wellbeing,' she said.
Malaysian Reserve
a day ago
- Malaysian Reserve
Molecular Point-of-Care (mPOC) Market Reaches $1.8 Billion: Kalorama Report Spotlights Rapid PCR Innovation and Expanding Frontiers in STI and HAI Testing
ARLINGTON, Va., June 20, 2025 /PRNewswire/ — Kalorama Information, a leading authority in in vitro diagnostics (IVD) market research, has released Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024–2029, estimating the global mPOC market at $1.8 billion in 2024. The report offers a comprehensive forecast through 2029, highlighting transformative opportunities in respiratory, sexually transmitted, and hospital-acquired infection diagnostics at or near the point of care. 'While the molecular point-of-care market saw unprecedented acceleration during the COVID-19 pandemic, Kalorama's latest analysis reveals it now stands on a firmer foundation with renewed growth expected,' said Justin Saeks, senior market analyst and report author. 'We anticipate an almost double-digit compound annual growth rate for the 'true' mPOC segment as demand spreads beyond COVID to broader respiratory panels, STIs, HAIs, and tropical diseases.' Key Findings from the Report: Respiratory testing dominates the market, with COVID-19, flu, strep, and RSV continuing to drive system adoption, particularly for combination tests. Growth expected in HAIs and STIs, although these will evolve more slowly due to testing infrastructure and workflow differences across care settings. 'True' mPOC segment revenues, which had recently declined, are projected to achieve a substantial CAGR from 2024 to 2029. Kalorama differentiates between 'true' mPOC platforms and near-patient systems, offering detailed segmentation by company, region, and disease target. Abbott and Cepheid lead their respective segments. True mPOC Systems: Compact, fast, CLIA-waived (or with waiver potential), and operable by non-lab personnel. Key players include Abbott (market leader), Roche, Cepheid, QuidelOrtho, BioFire, and Sekisui. Near-Patient Molecular Systems: Encompasses larger non-POC systems and smaller platforms with POC or near-POC potential. BioFire and Cepheid are major competitors, with Cepheid leading this segment. Why It Matters Now The report's release is timely as healthcare providers seek diagnostic solutions that balance speed, accuracy, and accessibility across both developed and resource-limited settings. mPOC systems bring the power of molecular testing to emergency departments, outpatient clinics, nursing homes, mobile labs, and even homes—enabling timely treatment decisions and improving care outcomes. 'POC molecular diagnostics represent one of the most important intersections between innovation and access in global health,' said Alisa Alvich, Marketing Director at Science and Medicine Group, Kalorama Information's parent company. 'Kalorama's analysis shows where this market is headed and what players must consider to stay competitive.' Audience Impact This research is essential for: Product Managers and R&D leaders developing decentralized molecular platforms. Corporate strategy teams evaluating new market opportunities or CLIA-waived innovations. Investors and M&A professionals scouting high-growth segments or acquisition targets. Clinical lab and procurement teams optimizing test menus for decentralized care delivery. With deep dives into market sizing, disease applications, regional dynamics, and competitive intelligence, Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024–2029 equips life sciences professionals with the insights needed to navigate a rapidly evolving diagnostics frontier. Get the Report Molecular Point-of-Care (mPOC) Market Outlook and Innovations, 2024–2029 is now available for purchase at: For purchasing inquiries or to schedule a custom consultation, contact:Sheri Davie – Sales Director, Kalorama About Kalorama Information Kalorama Information, part of Science and Medicine Group Inc., is a trusted publisher of market research exclusively focused on the healthcare industry. For over 25 years, Kalorama has delivered accurate, timely, and strategic intelligence to leaders in biotechnology, clinical diagnostics, in vitro diagnostics (IVD), pharmaceuticals, medical devices, and broader healthcare sectors. Originally launched in 1998, Kalorama Information quickly established itself as a premier source of insight into U.S. and global medical markets. Today, Kalorama remains a leading authority on healthcare market dynamics, with a particular emphasis on IVD. Kalorama is best known for its flagship title, The Worldwide Market for In Vitro Diagnostic Tests, an internationally recognized benchmark in the diagnostics field. Other reports published throughout the year cover these and other healthcare topics in greater detail. Our innovative approach to research, combined with deep industry expertise, has made Kalorama a go-to resource for top healthcare companies, strategic planners, investors, and media seeking authoritative market data and trends. With a singular focus on healthcare, Kalorama continues to shape informed decision-making across the industry through comprehensive, evidence-based analysis. Kalorama also works in coordination with other Science and Medicine Group brands, including BioInformatics, which focuses on life science markets and marketing, SDi, the leading source of information on the laboratory life science and analytical instrumentation industry and publisher of IBO, its twice-monthly newsletter, and IMV, which publishes reports and data on the medical imaging and clinical markets. For more information about Kalorama Information and other services offered by Science and Medicine Group, please visit our website.
